These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2564000)

  • 1. H2-antagonists and carmustine.
    Dorr RT; Soble MJ
    J Cancer Res Clin Oncol; 1989; 115(1):41-6. PubMed ID: 2564000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of cimetidine but not ranitidine with cyclophosphamide in mice.
    Dorr RT; Soble MJ; Alberts DS
    Cancer Res; 1986 Apr; 46(4 Pt 1):1795-9. PubMed ID: 3948164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cimetidine enhances cisplatin toxicity in mice.
    Dorr RT; Soble MJ
    J Cancer Res Clin Oncol; 1988; 114(1):1-2. PubMed ID: 3350834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L-histidinol improves the selectivity and efficacy of alkylating agents and daunomycin in mice with P388 leukaemia.
    Warrington RC; Fang WD
    Br J Cancer; 1989 Nov; 60(5):652-6. PubMed ID: 2803940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cimetidine enhancement of cyclophosphamide antitumour activity.
    Dorr RT; Alberts DS
    Br J Cancer; 1982 Jan; 45(1):35-43. PubMed ID: 7059463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced antitumor activity and reduced toxicity of 1,3-bis(2-chloroethyl)-1-nitrosourea administered in lipid microspheres to tumor-bearing mice.
    Takenaga M; Igarashi R; Tsuji H; Mizushima Y
    Jpn J Cancer Res; 1993 Oct; 84(10):1078-85. PubMed ID: 8226282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of pharmacologic doses of zinc on the therapeutic index of brain tumor chemotherapy with carmustine.
    Roosen N; Doz F; Yeomans KL; Dougherty DV; Rosenblum ML
    Cancer Chemother Pharmacol; 1994; 34(5):385-92. PubMed ID: 7520843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 6-[Bis(2-chloroethyl)amino]-6-deoxygalactopyranose hydrochloride (C6-galactose mustard), a new alkylating agent with reduced bone marrow toxicity.
    Schein PS; Green D; Dean SW; McPherson E
    Cancer Res; 1987 Feb; 47(3):696-9. PubMed ID: 3802075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Schedule-dependent variations in the response of murine P388 leukemia to cyclophosphamide in combination with interferons-alpha/beta.
    Borden EC; Sidky YA; Hatcher JF; Bryan GT
    Cancer Res; 1988 May; 48(9):2329-34. PubMed ID: 3356000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elimination of EL-4 and L1210 murine tumors by 1,3-bis (2-chloroethyl)-1-nitrosourea requires an intact immune response.
    Steele TA; Cox DC
    Proc Soc Exp Biol Med; 1996 May; 212(1):63-8. PubMed ID: 8618953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The chemopreventive effect of dimethylthiourea against carmustine-induced myelotoxicity in rats.
    El-Sayed el-SM; Abdel-Aziz AA; Saleh S; Saad AS
    Food Chem Toxicol; 2011 Sep; 49(9):1965-9. PubMed ID: 21620922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo enhanced antitumor activity of carmustine [N,N'-bis(2-chloroethyl)-N-nitrosourea] by simvastatin.
    Soma MR; Baetta R; De Renzis MR; Mazzini G; Davegna C; Magrassi L; Butti G; Pezzotta S; Paoletti R; Fumagalli R
    Cancer Res; 1995 Feb; 55(3):597-602. PubMed ID: 7834630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor activity and bone marrow toxicity of aminoglucose mustard anticancer agents in mice.
    Cantrell JE; Green D; Schein PS
    Cancer Res; 1986 May; 46(5):2340-3. PubMed ID: 2938728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eradication of a disseminated mouse lymphoma by 1,3-bis(2-chloroethyl)-1-nitrosourea is immunologically mediated and accompanied by de novo generation of anti-tumor cytotoxicity.
    Sensi M; Bergomi M; Formelli F; Parmiani G
    Int J Cancer; 1990 Dec; 46(6):1088-94. PubMed ID: 2249896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced acute lung damage in mice following administration of 1,3-bis(2-chloroethyl)-1-nitrosourea.
    Kehrer JP; Klein-Szanto AJ
    Cancer Res; 1985 Nov; 45(11 Pt 2):5707-13. PubMed ID: 4053044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth and rejection of leukemia cells in individual mice after combined treatment with amphotericin B and 1,3-bis(2-chloroethyl)-1-nitrosourea.
    Valeriote F; Lynch R; Medoff G; Tolen S; Dieckman J
    J Natl Cancer Inst; 1978 Aug; 61(2):399-402. PubMed ID: 277727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of primary radiogenic C57BL mouse cell leukemia/lymphoma by 1,3-bis(2-chloroethyl)-1-nitrosourea chemotherapy and adjuvant cellular therapy.
    Maruyama Y; Feola JM; Kryscio R
    Jpn J Cancer Res; 1985 Dec; 76(12):1236-43. PubMed ID: 3005211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitrosourea-misonidazole combination chemotherapy: effect on KHT sarcomas, marrow stem cells and gut.
    Mulcahy RT; Siemann DW; Sutherland RM
    Br J Cancer; 1982 Jun; 45(6):835-42. PubMed ID: 6212075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of BCNU pulmonary toxicity in patients with malignant gliomas: an assessment of risk factors.
    Aronin PA; Mahaley MS; Rudnick SA; Dudka L; Donohue JF; Selker RG; Moore P
    N Engl J Med; 1980 Jul; 303(4):183-8. PubMed ID: 7383088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between DNA damage and the inhibition of stem cells in murine bone marrow after single and repeated administration of BCNU and HECNU.
    Berger MR; Henne T; Bedford P
    J Cancer Res Clin Oncol; 1985; 110(3):185-90. PubMed ID: 4077917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.